- Home
- PMCB vs SNES Comparison
PMCB vs SNES Comparison
Compare PMCB & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- SNES
- Stock Information
- Founded
- PMCB 1996
- SNES 2004
- Country
- PMCB United States
- SNES United States
- Employees
- PMCB N/A
- SNES N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- SNES Agricultural Chemicals
- Sector
- PMCB Health Care
- SNES Industrials
- Exchange
- PMCB Nasdaq
- SNES Nasdaq
- Market Cap
- PMCB 7.6M
- SNES 6.7M
- IPO Year
- PMCB N/A
- SNES 2016
- Fundamental
- Price
- PMCB $1.05
- SNES $4.80
- Analyst Decision
- PMCB
- SNES Strong Buy
- Analyst Count
- PMCB 0
- SNES 1
- Target Price
- PMCB N/A
- SNES $10.00
- AVG Volume (30 Days)
- PMCB 8.5K
- SNES 228.1K
- Earning Date
- PMCB 08-12-2025
- SNES 08-07-2025
- Dividend Yield
- PMCB N/A
- SNES N/A
- EPS Growth
- PMCB N/A
- SNES N/A
- EPS
- PMCB 1.29
- SNES N/A
- Revenue
- PMCB N/A
- SNES $1,927,000.00
- Revenue This Year
- PMCB N/A
- SNES $130.53
- Revenue Next Year
- PMCB N/A
- SNES $80.00
- P/E Ratio
- PMCB $0.82
- SNES N/A
- Revenue Growth
- PMCB N/A
- SNES 40.15
- 52 Week Low
- PMCB $1.00
- SNES $1.30
- 52 Week High
- PMCB $2.42
- SNES $6.48
- Technical
- Relative Strength Index (RSI)
- PMCB 47.26
- SNES 76.68
- Support Level
- PMCB $1.00
- SNES $3.56
- Resistance Level
- PMCB $1.07
- SNES $4.46
- Average True Range (ATR)
- PMCB 0.05
- SNES 0.38
- MACD
- PMCB 0.01
- SNES 0.10
- Stochastic Oscillator
- PMCB 39.78
- SNES 97.61
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.